celastrol has been researched along with Kidney Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Qin, L; Qin, Y; Shi, Y; Wang, W; Zhang, C; Zhu, N | 1 |
| Deng, C; Li, H; Qin, L; Zeng, Q; Zhang, C; Zhu, N | 1 |
| Bao, Y; Kakehi, Y; Kanematsu, A; Kita, Y; Kobayashi, T; Wu, X; Yamamoto, S | 1 |
3 other study(ies) available for celastrol and Kidney Neoplasms
| Article | Year |
|---|---|
GSH-specific fluorescent probe for sensing, bioimaging, rapid screening of natural inhibitor Celastrol and ccRCC theranostics.
Topics: Animals; Carcinoma, Renal Cell; Fluorescent Dyes; Glutathione; Kidney Neoplasms; Precision Medicine | 2023 |
An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis.
Topics: Carcinoma; Carcinoma, Renal Cell; Ferroptosis; Fluorescent Dyes; Glutathione; Humans; Kidney Neoplasms | 2023 |
Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.
Topics: Apoptosis; Carcinoma, Renal Cell; Caspase 8; Caspases; Cell Line, Tumor; Humans; Kidney Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2024 |